Mestnaya analgeziruyushchaya terapiya pri osteoartrite
- Authors: Delyagin V.1,2
-
Affiliations:
- Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology
- Medical InformationAgency «MedForum»
- Issue: Vol 27, No 3 (2016)
- Pages: 49-52
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116540
- ID: 116540
Cite item
Open Access
Access granted
Abstract
Osteoarthritis is a frequent degenerative disease of the articular cartilage with interest the actual bones. Risk factors include genetics, obesity, female gender, advanced age, previous injury. Diagnosis is based on history and radiographic findings. Laboratory studies have shown only for differential diagnosis. The clinical picture is reduced to restrict movements of pain, joint deformity. The nonsteroidal anti-inflammatory drugs, including topical administration (dolgit = ibuprofen) are recommended as symptomatic therapy.
Full Text
About the authors
V. Delyagin
Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology; Medical InformationAgency «MedForum»
Email: delyagin-doktor@yandex.ru
Professor Moscow
References
- Block J., Scanzello C. Osteoarthritis. In: Goldman-Ceccil Medicine. 25th Ed., 2016; 1744-8.
- Lozada C. Osteoartritis. Updated Mar 27, 2015 http://emedicine.medscape.com/article/330487-overview
- Woolf A., Pfleger B. Burden of major musculoskeletal conditions // Bull World Health Organ. - 2003; 81: 646-56.
- Siegenthaler W. Differentialdiagnose Innere Krankheiten. Von Symptom zur Diagnose / Stuttgart: Thieme Verlag, 2005; 520.
- Glyn-Jones S., Palmet A., Agricola R. et al. Oateoarthritis // Lancet. - 2015; 286: 376-87.
- Baarsen L., Lebre M., van der Coelen D. et al. Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy? // Arthritis Res. Ther. - 2014; 16 (4): 426.
- Radin E., Paul I. Response of joints to impact loading. I. In vitro wear // Arthritis Rheum. - 1971; 14 (3): 356-62.
- Burkitt H., Stevens A., Lowe J. Skeletal system. Basic Histopathology. 3rd Ed. / New York, NY: Churchill Livingstone, 1996; 260.
- Hamerman D. The biology of osteoarthritis // N. Engl. J. Med. - 1989; 320 (20): 1322-30.
- Howell D. Pathogenesis of osteoarthritis // Am. J. Med. - 1986; 80 (4B): 24-8.
- Cesare P., Dominik R., Samuel J. et al. Pathogenesis of osteoarthrosis. In: Kelley's Textbook of Rheumatology. 9th Ed / Elsevier Inc., 2013; 1617-38.
- Abramson S., Attur M. Developments in the scientific understanding of osteoarthritis // Arthritis Res. Ther. - 2009; 11 (3): 227.
- Sinusas K. Osteoarthritis: diagnosis and treatment // Am. Fam. Physician. -2012; 85 (1): 49-56.
- Морозова Т.Е., Рыкова С.М. Ибупрофен в практике врача-терапевта: возможности в купировании болевых синдромов // Лечащий врач. - 2013; 1: 45-9.
- Aabakken L. NSAID-associated gastrointestinal damage: methodological considerations and a review of the experience with enteric coated naproxen // Eur. J. Rheumatol. Inflamm. - 1992; 12 (2): 9-20.
- Russell R. Non-steroidal anti-inflammatory drugs and gastrointestinal damage-problems and solutions // Postgrad. Med. J. - 2001; 77 (904): 82-8.
- Underwood M., Ashby D., Cross P. et al. Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study // BMJ. - 2008; 336 (7636): 138-42.
- Tiso R., Tong-Ngork S., Fredlund K. Oral versus topical Ibuprofen for chronic knee pain: a prospective randomized pilot study // Pain Physician. - 2010; 13 (5): 457-67.
- Whitefield M., O’Kane C., Anderson S. Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study // J. Clin. Pharm. Ther. - 2002; 27 (6): 409-17.
Supplementary files
